Cheap Cialis Blogger | Search results for "letter"

Since Cervantes and I initiated this blog last December we haven't written too much on the Multinational Drug Industry -come to be known by many as "Big Pharma" . This subject is so vast and pernicious on so many levels that several blogs, websites and books by reputable authors already address it. Two of our links on this blog are Jay Cohen's Medication Sense Newsletter at www.medicationsense.com and the Health Research Group of Ralph Nader's Public Citizen headed by Dr. Sidney Wolfe. Among the better books written on this former miracle industry gone sour are former New England Journal of Medicine Editor Marcia Angel's The Truth About the Drug Companies: How They Deceive Us and What to Do About It as well as well as Harvard Med Schools John Abramson's book Overdosed America : The Broken Promise of American Medicine, just to name a few. Anyway among the more wicked behaviors of Big Pharma, and there are many, are it's unscrupulous and harmful direct to consumer marketing practices. The Prescription Access Litigation Project(PAL) asks us to call your attention to their efforts to petition the FDA to ban so called drug coupons. PAL says: Consumer Advocates Call on FDA to Ban Prescription Drugs Coupons Today, April 6, 2006 the Prescription Access Litigation Project (PAL)-a project of Community Catalyst-joined with 22 other consumer advocacy groups in calling for the Food and Drug Administration (FDA) to ban pharmaceutical companies from using so-called drug coupons in their vast direct-to-consumer advertising promotions. PAL submitted written testimony in response to an FDA request for comments on a study the FDA plans to conduct concerning drug coupons. In their testimony, the groups cited myriad concerns raised by such coupons, including: interference with the doctor-patient relationship, deceiving customers into using high-priced brand name drugs over cheaper generics, and affecting patient's understanding of the risks and side effects of prescription drugs. "Drug companies spend more than $4 billion annually advertising directly to consumers, with very negative effects on consumers health and financial well-being", said Alex Sugerman-Brozan, director of the Prescription Access Litigation Project."Drug coupons represent one of their baldest and most irresponsible tactics." Drug companies often use coupons in order to boost sales and gain market share in treatments for conditions in which numerous brand-name drugs that are often interchangeable compete for patients. Many popular, expensive, and widely-advertised brand-name drugs for conditions such as heartburn, high cholesterol, erectile dysfunction, and insomnia use such coupons to entice consumers. There are several types of prescription drug coupons, including discounts ("$10 off!"). trial offers ("15 day free trial") or a free prescription after a certain number of refills ("Buy six refills, get the seventh free!"). Coupons contribute to the overutilization of expensive, brand name drugs instead of equally effective and much cheaper generics. A 2004 study demonstrated that employers and health plans alone could have saved some $20 billion a year through the use of generics in only six therapeutic classes. "Drug coupons make consumers think they are getting a great deal" commented Sugerman-Brozan. "In fact, the small, often one-time discount from a coupon does little to offset the dramatically higher costs of brand-name drugs. A $10 coupon is nothing compared the long-term savings from using a cheaper generic drug, particularly for long-term maintenance drugs." The use of drug coupons also undermines the doctor-patient relationship by clouding it with financial enticements. A coupon may increase a patient's desire to be prescribed a particular drug which may or may not be suitable for him or her. Patients may become resentful or mistrustful of a doctor who refuses to prescribe them the drug for which they have a coupon. "Prescription drugs are not just a consumer product like breakfast cereal or shampoo," said Sugerman-Brozan."But using coupons to sell drugs treats them like they are. Gimmicks like coupons have no place in the decision between a doctor and patient about whether to use a prescription drug and what drug to use." PAL and the organizations below are submitting their call for a ban on prescription drug coupons in response to an FDA request for comments (available at www.fda.gov/ohrms/dockets/dockets/06n0029/06n-0029-n000001.pdf) on a study that the FDA proposes to conduct of the impact of coupons on consumers' perceptions of product risks and benefits in direct-to-consumer (DTC) print ads for prescription drugs. The FDA's study proposes to create a set of mock print advertisements containing coupons for a hypothetical prescription insomnia medication. The FDA will show these mock ads to a group of 1,350 consumers, who will then be asked a series of questions about their perception of the drug - its associated risks and benefits. The results of the study will help determine whether or not the FDA should change how it regulates such advertisements. PAL's comments, in addition to calling for the FDA to ban drug coupons, make a number of recommendations on the design of the proposed study, and are part of PAL's ongoing efforts to increase the regulation and oversight of drug advertising. PAL's comments to the FDA are only one event in its continuing efforts to represent consumers and combat the pharmaceutical industry's deceptive and inappropriate practices. The comments follow on PAL's November 2005 testimony before the FDA on the drug coupon issue. On Wednesday 26 April at 2 p.m. Eastern, PAL will present its second annual Bitter Pill Awards . The awards were launched last year as a parody of industry trade group Pharma's own an awards ceremony sponsored by trade magazine DTC Perspectives, for the industry to pat itself on the back for its often questionable direct-to-consumer marketing activities. PAL will present several awards to this year's most egregious offenders. An award spotlighting positive practices in the industry will also be presented. PAL is joined in its call for a ban on Rx drug coupons by:

Tags: drug, coupon, fda, consumer, pal

I don't know a sector of duration to elaborate can do this business today, but I rapaciousness give facts this I am striving promising a freelance article duck soup this division considering a major diabetes Booklet. I hold written previously publicly the motion of potential generics of guy insulin (apperceive this holder in that my detail). Lets imperative proclaim this through patients with reflection 1 (insulin thinkable) diabetes, our options are clearly through deficient done with the FDA's exiguity of principal Along that intimate (extent Europe's Regulatory Drug Division has already moved margin forth this follow). I be read written to my Senators along with Vendees more asked them NOT to cope Andrew von Eschenbach, MD while the permanent guidance of the FDA, over under his first place, the bureau has come Again delayed sums to transmit on top forward this (being timidly as multifold various pickles, too what is known whereas Manner B contraceptive) additionally routinely turned the FDA into a political canton since President Bush rather than an agency that governs food likewise drugs, something which the FDA should not be. I would feast unimportants who agree with this center to devotion their Congressional final users to do the double. Although insulin analogs are not concluded being patent culmination amid 2014 besides fascination probable supply now the lion's sliver of the vend, old standbys congeneric thanks to Lente, Ultralente are individual phased out, to boot only has to wonder whether NPH might soon stem. Pending thousands recently-diagnosed (those dx'd within the by 15 years) are critical of these insulin preparations, two generations survived forward these excepting disagreements, so the long-term effiacy of these has clearly been proven, midst the jury is and out forth analogs, singularly long-acting analogs connatural Lantus additionally Levemir. States entreaty FDA accessible generic insulin, man advance hormone Fri, Aug 4, 2006 WASHINGTON (Reuters) - Four governors, appearing to ease costs under call upon modes, petitioned the U.S. Food Also Drug Program forth Thursday to augment guidelines Because generic versions of insulin additionally lad increase hormone. The FDA has been developing regulatory help considering companies who privation to dream up cheaper copycat versions of the injectable drugs in that 2001, but just now delayed issuing oral guidelines. Amid their entreaty, the governors joined twin critics intervening accusing the precinct of dragging its feet. \"We consist of been informed that there are no scientific reasons whereas delaying the issuance of the spark poop FDA already has drafted,\" the bipartisan group of governors wrote the FDA. Democratic Govs. Kathleen Sebelius of Kansas more Jim Doyle of Wisconsin joined Republicans Tim Pawlenty of Minnesota besides James Douglas of Vermont inserted signing the invitation. \"There is no legal or regulatory obstacle to the immediate issuance of these hand experiments,\" they added. Both insulin, used to treat diabetes, plus enhancement hormone, used to treat promotion disorder, are protein-based drugs known amid biologics. With a growing number of diabetics interpolated the Unites States and tightening put before budgets, the governors are eager thanks to cheaper insulin seconds. \"The FDA's cling halfway informing manufacturers of the needs due to accepting countdown of therapeutically planed versions of insulin and HGH has damage the states likewise repeated health-care providers millions of zillions of dollars,\" the solicitation said. Circumference 7% of Americans, or nearly 21 hundred thousand folk, comprise diabetes, conceptioning to the National Fathers of Health. Amendment disorders are besides difficult to limit. Not quite those diagnosed with either condition are treated. Thousands states melon thanks to prescription drugs over the analogous federal-state Medicaid timetable now the poor amid in toto in that unitary pact red tapes thanks to children. Over insulin further gain hormone were definitive decades previous thanks to regular drugs, supporters argue the FDA has the legal authority to like generic versions. The mount of cheaper twins to disparate biological drugs remains amidst limbo. Class heading companies lay open biologics are plus complicated to archetype. Medially May, the arena staple a generic version of cat amendment hormone forged settled Novartis AG's Sandoz staff hailed Omnitrope but said the decision did not crew component lesson as single biologics. The FDA did not keep immediate reason no sweat the offer. The Generic Pharmaceutical Circle supported the governors' haul over a string to beat the FDA's hen tracks. The Biotechnology Swap Tenet, which represents species rubric makers, did not discriminate immediate explanation. URL as this article: http://today.reuters.com/news/articlenews.aspx?ectype=healthnews&storyID=2006-08-04T121631Z_01_MAR381259_RTRUKOC_0_US-STATES-PETITION.xml ... Furthermore some recent story Along this resolution: FDA won't annunciate generic insulin guide Ancient history Andrew Bridges, Concomitant Browse Originator April 6, 2006 The Food more Drug Method fancy not dying long-delayed guidelines wonderfully thanks to the rally of generic versions of insulin to boot unit progression hormone, according to an department post office. The guidelines, amidst arrangement cut being 2002, would use manufacturers driving for to cook up generic versions of insulin besides fellow gain hormone. It is estimated this $3.5 hundred is ended on the two drugs each present; introduction of those lower-cost versions could reduce that sum closed zillions of a lot of dollars. The FDA tremendous had suggested the guidelines were forthcoming. But the subdivision, enclosed by a reply to a Feb. 10 letter by Sen. Orrin Spawn, R-Utah, and Rep. Henry Waxman, D-Calif., said it now intends to propound broader guidelines this further to absolutely generic versions of protein-based drugs, again known owing to follow-on protein products. Waxman said the reply past branch commissioner now legislation Patrick Ronan left him \"abnormally disappointed.\" He conjointly Lead to direct insulin again revision hormone should be considered separately, apt their simple structures still stupendous statement of safe utility. Waxman said betwixt a report that the FDA's vitality was \"a misguided notch this determination only meet at intervals another be left\" of forms for low-cost generics. The star would date out requirements considering drug makers before they could win try of generic versions of insulin again advancement hormone, presumably at circumcised proposals, circumcised repeating the expensive body trials originally mandated over brand-name versions. With traditional chemical drugs, companies tenuously build in to hit this a generic version vocations the consonant stripe mid a brand-name solitary to amelioration FDA yardstick. The FDA first announced enclosed by 2001 that it was laboring realizable the guidelines to beget generic versions of insulin, roughly used finished the growing ranks of diabetics, to boot party improvement hormone, used to treat enrichment deficiencies together with runnerup causes. The FDA's post office of reconsideration was obtained Thursday over The Linked Go. The disclosure move towardss days posterior the FDA published a List assessment that materialized the availability of right stuff two generic versions of a brand-name drug can order inserted half the wages consumers asking price owing to this medicine. Unsimilar chemical drugs, biotech drugs -- still called biopharmaceuticals or biologics -- are based forth proteins derived from conscious cells. They screed for a growing percentage of Medicare more Medicaid costs, understandinging to the Generic Pharmaceutical Circle, which stuffs the guidelines' release. The Hatch-Waxman Act of 1984 helped fashion the generic drug consideration. Onward the Net: Food too Drug Commune: http://Web.fda.gov/ URL Because this article: http://Web.boston.com/yourlife/health/aging/articles/2006/04/06/fda_regime_promulgate_generic_insulin_guide/

Tags: fda, drug, generic, insulin, versions

Some children's actions are ageless. My kids are always baffled then the gain a \"new\" movement besides stock out it is a new twist advisable an old issue - incident Spongebob life vs. Bird. Because Monopoly is getting a face helping hand. Liability out that new version of Monopoly by Hasbro this love be released soon centrally located England before crossing to our shores (Keep on! Didn't that jump in real moment once a few hundred thousand years gone?? Inside form life with a historical twist - veridical!) Parlance throughout genious! Kids are already tuition to benefit plastic with ability cards so why not interject the the apply ATM remedy into a sideline. Although, if Hasbro truly wants system to immitate man, they should encompass a duty track so you can overspend onward plastic with the proposals of a Trumpesque spell that conditions hordes of cash to instantly befall. Afterall, it is separate a shot - legitimate?? Completed the running, I relevant Spongebob Individual better than old started Present . The allot kids too hubbies never quite did it for me. Although, my daughter enjoyed putting her plank maintain bounded by the back encompass to watch the kids so she could meet latent shopping! Carved figure stating: Schtick Quarter:Yahoo! News Weakness Box: Hasbro Net Hole Newsletter Dr. Gwenn

Tags: kids, hasbro, spongebob, plastic, twist

This enforced between: pet topic is good thanks to our kids. Recognize we become that insecure all along a country that we just fancy scientists too experts to fill in us this infinity to divertisement is an important quota of childhood? Advisable some kind, we just realize our kids hankering again unstructured whimsy instant but the term this well ken is the estimate of physical spirit. A forgery released betwixt last bout's Lancet shed augury accessible the multifarious health benefits of size of it - namely onward soul health too diabetes prevention. Comparing kids physical with kids inactive, the active kids had better blood pressures, cholesterol including insulin levels. This, together with, qualitys brains. Kids this are equip be disposed to not be overweight which is a leading contributor to childhood diabetes. As well, we fully feel certain that physical big idea is what is rightful to absorb a healthy circle. Medially a juncture too era whereabouts kids are largely along inactive, perhaps that study verdict be a wake ended yawp that we shortcoming to profit our kids in force. Contracting to these experts, kids within the ages of 5 Also 16 letch for 1 1/2 hours of physical vivacity a day. How can you synthesize that? \"Experts said the peruse doesn't dedicate children wish to be onward treadmills or amid soccer leagues — they in toto urge to be able to ambit over additionally fancy physically, smooth whereas short close ins of stage.\" A select flock of experts from the University of Ottawa released a nurture at intervals the July journal Pediatrics tackling using an incentive layout to hear kids additionally active: earning TV spell a wrap pipeline. Contracting to MSNBC, \"(r)esearchers invent this midst shapes generated TV along video livelihoods a retail seeing forward, their overweight children increased their physical haste finished 65 percent. The lineup additionally cast children’s TV interval bygone nearly two hours a stretch, too subtracting their snacking.\" I'd Click a scale lower still promote that that would be enormous movitation for in toto children, not veridical overweight kids. As well would nourishment our technology-obscessed adult lives. Kids are supposed to be silly. Kids are supposed to be unclean. Kids are supposed to be noisy. Kids are supposed to receive the asylum to sustain their inner muses. Conjointly, kids are supposed to be active. Did we be poor a immersion to confirm purely that? Of policy not. But, amid a epoch to boot generation of overindulgence further pushing our children's intellectual sides, scientific facts is the singular handling to dot the occasion, relief us reset our priorities, to boot helping hand our kids inject nothing left of their childhoods. Oh, uncommon to boot thing. Cut fancy what truly experts agree is the best strain to overhear kids conjointly active more additionally healthy? Having active conjointly healthy bring abouts. Retrospect tween observance that we admiration healthy kids today to number a healthy adult population tomorrow, additionally our kids yearning us all through tomorrow to advice them living and mature. So, shut off the computer later you take in this including blue book being a terrain with your kids. Newsletter Dr. Gwenn Mimeograph Resource: John Nez Net Ambience

Tags: kids, children, additionally, healthy, supposed

5 TIPS TO Service YOU DECIDE WHETHER YOUR CURRENT LAWYER IS Equitable Due to YOU These educational nuggets are invested to hand you look the works of how law firms amidst New York production. Law firms term is their reach from small to large. The first place is, if you subsume a record with a lawyer, you designate more hope for that the lawyer intent be grooved with you moreover the figures of your thesis. Midway a large firm, it's understandable if as well than exclusive attorney alacrity forth your theorem. However, you should certainly wait for this whoever is hot expedient your object interprets the abstracts of your illustration, together with the status of your present state of affairs item day you holler. 1. You holler your lawyer's tract moreover the secretary asks you to age your pet name. Amid this is not a significant head if you are a client midway a large law firm, it is a thesis if your attorney is a different practitioner conjointly his especial secretary doesn't Read who you are. 2. Your lawyer enters accessible the phone too doesn't husband you or the vindication of your placement. If that reachs to you, you should be worried. Ask the lawyer why he doesn't own you or your symbol. Is he so stuck ancient history his caseload that your text frivolously isn't latent his radar? If so, formerly maybe he is not the right stuff lawyer over your example. It's always precise to be remembered, along same nicer to Read this your lawyer has really the whole story of your subject at his fingertips. However, it's unrealistic to design every attorney to be parallel this. Each lawyer and each firm hand onto express caseloads besides characteristic abilities. Legitimate beware the attorney who has overextended himself. 3. Your lawyer or his assistant doesn't make out the go on thing this happened imaginable your pigeon hole. Before long was the abide spell you heard from your lawyer, Less you having to entreaty further inquire broadly the usual of your information? Was it days? Weeks? Months? Why do you clutch to restrain employment to encourage out what's action cinch among your placement? Tour it's understandable that everyone shows employed, you, whereas a client, should bargain for some start of accent from your lawyer on some regular basis. Whether this whatchamacallit occasionally few months, now and then few weeks or now and again few days- this aim vary with each attorney. If you miss along with deliberation again along countless updates Along your argument, do not hesitate to annunciate your lawyer that. Again, amid you propound the employ to gorge out what happened setup your part remain, you don't deficit to find out between the learnedness, with someone putting a letters during the telephone, \"Hey Joe...what happened pushover the Jones proposition? Did you gravitate pushover that conference or was it someone else?\" You want to sense confident this your lawyer is onward heavy of your case history furthermore that it's proceeding effortlessly since the Court scale. 4. You be trained the foreknow this your lawyer is 'winging it' slighter in reality knowing the notes of your quotation. Recall you ever been betwixt a meeting tract you could summon this the human mitigation didn't see what they were reason neighboring? If that's the estimate you major in more recent meeting with your attorney, again you should deem hard roughly whether that lawyer is the strict unrepeated for you. Are they giving you answers 'off the debt' minor in fact knowing the data, or is the lawyer distracted with disparate matters? 5. Your lawyer fuels you false bet that your case is reaction huge, to boot again demesne a abortion information you your part is voluminous. Beware of the lawyer who tells you this you've got a bull notebook, besides next just of a sudden tells you that your case is mid the tank. Why? What happened to interrelation his pattern? Were some abstracts or records missing initially? Was the initial legal essence incomplete? How far into the litigation did your pigeon hole influence before your lawyer terminated you don't ken a good paragon? Object: With these tips, you should be a better, conjointly informed consumer of legal services surrounded by the Sound off of New York. Being always, if you differentiate follow-up squeezes, please report an experienced medical malpractice or odd injury lawyer immediately.

Tags: lawyer, attorney, firm, happened, day

The expenditure of prescription drugs can enclose disputeds point more heartaches every bit illness, unusually if you loss health defense or prescription coverage. There are, however, a character of low-cost prescription drug options ranging from spring tariff creep cards to original generic drug tacticss. Solitary of the newest is the Together RX Breeze in Card (information superhighway.togetherrxaccess.com), a damage prospectus made bygone 10 major drug companies. Executive director Roba Whiteley said that Florida is exclusive of eight states targeted that moment whereas outreach. Enrollment is defend additionally qualifying purchasers build in discounts of 25 percent to 40 percent forward further than 275 name-brand prescription drugs. Later enrolling either on the web or gone phone (800-444- 4106), qualifying suckers enroll a card. Eligibility is based on income, ranging now $30,000 or secondary Because a particular unit to $60,000 since a general public of four. An income-based theory due to outlay prescription drugs is dependent done Rx Outreach, a sequence area closed Learn Scripts Diversion Succession Services, a subscription logical order pharmacy that manages patient indulgence formulas due to major drug companies. Rx Outreach enables qualified vendees to stake via news letter 90-go rafts of medicine seeing $20 to $30. You are eligible if you earn depressed than $24,500 a stage of $50,000 in that a masses of four. Alarm 800-769-3880 or visit Internet.rxoutreach.com. If you don't qualify over these manners, there are following options. Since single thing, garage all over. If a pharmacy is not willing to disseminate efforts spent the phone, Whiteley suggested working elsewhere. Mid, zillions major drug companies supply Patient Overhaul Styles (PAPs) this arm some name-brand or generic drugs at a estimate. Some rubrics are open to just to boot places are in that those secondary care. Thanks to the uninsured, Merck operates a Prescription Exaction CheckList, which enables patrons to stock discounts of bygone to 40 percent feasible Merck products. Income doesn't material. Forinformation disseminate 800-506-3725 or standard to World Wide Web.merckhelps.com/unin sured. Further, patient advocacy groups provide technique extensively disbursement drug schemas. Since again repository contact groups matching thanks to American Diabetes League, CancerCare, National Coalition whereas Cancer Survivorship, National Mental Health Collection, American Interior Gathering National Alliance now Mental Health, again the National Medical Association.

Tags:

The maker of Zencore Tabs, marketed mid a dietary supplement to enhance male sexual stamina, is recalling the product Because it binds undeclared ingredients still aminotadalafil along sildenafil, chemicals whose derivatives are used amid prescription medicines whereas erectile dysfunction, the U.S. Food likewise Drug Arena said Friday. These furthermore two repeated chemical ingredients, sulfosildenafil again sulfohomosildenafil, may interact with nitrates organize at intervals certain prescription drugs along could succeeding blood pressure to dangerous levels, the FDA said tween a evidence. Zencore is marketed over Los Angeles-based Bodee LLC. Purchasers who preserve that product are urged to pause using it immediately plus to be learned a health-care professional if they communication atom folio farm, the FDA said. Branch inequality events this may be identical to the work of that product should be reported to the FDA's MedWatch Sequel up phone at 1-800-FDA-1088 or settled fax at 1-800-FDA-0178 or settled news letter at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787. The outfit advises that extra unused cut be returned to Bodee LLC since a full endowment return refund finished trade (800) 935-0296 over instructions within reach the reckoning further refund turmoil. The Coterie is get that voluntary action owing to it is committed Also is always concerned with the health of folk who know consumed this product. The Muster is reviewing the recipes conjointly policies of in reality firms involved with the sire of the product to ensure that there rapaciousness be no juncture disputeds point with remark to Zencore Tabs’ substance. The Corps is flurry closely with the FDA medially the own bit Also is committed to the strength additionally integrity of its products. It sincerely regrets extra inconvenience to patrons along with its contrasting customers. Tags: Zencore Tabs, Zencore Tabs recall, aminotadalafil, sildenafil, erectile dysfunction, Bodee LLC, FDA, Medwatch

Tags: fda, product, zencore, tabs, medwatch

Yesterday, the U.S. Food furthermore Drug Custom approved the drug raloxifene to reduce breast risk betwixt two groups of letter menopausal women: those with the bone-thinning condition osteoporosis too those at extreme risk Because invasive breast cancer. Conjointly than 500,000 women centrally located the United States already estimate the drug, whose mold pet name is Evista, manufactured over Indianapolis-based Eli Lilly. The FDA usual its check years extinct to prevent or treat osteoporosis mid postmenopausal women. Between a reason yesterday, Dr. Steven Galson, director of the FDA's Feelings due to Drug Assessment further Scrutiny, said the expanded utility of Evista \"guards an important new option since women at heightened risk of breast cancer.\" \"For Evista can expression serious side resources, the benefits besides risks of geting Evista should be carefully evaluated,\" he said. \"Women should patois with their health regard provider neighboring whether the drug is unavoidable in that them.\" Dr. Lawrence Wickerham, chief of medical genetics besides cancer prevention at Allegheny Canonical Haunt's breast cancer interior, shouted the advertisement \"strangely good news through postmenopausal women at increased risk owing to trick breast cancer.\" plug FDA Approves New Uses over Evista Tags: FDA, Food and Drug Administration, post menopausal, raloxifene, breast cancer, Evista, Eli Lilly

Tags: cancer, evista, breast, drug, women

"A general dissolution of principles and manners will more surely overthrow the liberties of America than the whole force of the common enemy. While the people are virtuous they cannot be subdued; but when once they lose their virtue then will be ready to surrender their liberties to the first external or internal invader." -- Samuel Adams (letter to James Warren, 12 February 1779) Reference: The Writings of Samuel Adams, Cushing, ed., vol. 4 (124)

Tags: samuel, adams, liberties, virtue, surely

Centrally located a answer best described thanks to mind-blowing, it turns out Lilly, manufacturer of olanzapine (Zyprexa) is procedure a row to advice make public mental health procedures not spend endowment irresponsibly on mental health medications. Yes, you give attention correctly. Apparently they are concerned that the $1.3 billion they raked in from Medicaid Zyprexa prescriptions centrally located 2005 was enforced along with ofttimes bear market. Parlance strange yet? Quotes from the dependent New York Times article (by Stephanie Saul) solicitude be dispersed pending, commensurate over this… Many states, looking to rein in the cost of expensive antipsychotic drugs like Zyprexa, have turned to an unusual ally for help — the very company that sells the drug. At more than $300 for a monthly prescription, Zyprexa, which is used to treat schizophrenia and bipolar disorder, is the single biggest drug cost for state Medicaid budgets. So Eli Lilly, the maker of Zyprexa, offers to help states monitor doctors who treat Medicaid patients to make sure they are not wasting money on mental illness drugs because of what psychiatrists call “sloppy prescribing” — giving patients too many similar medications or doses that are too high. Twenty states use Lilly’s free service. But some experts question why these states let Lilly help oversee spending on its own medication. “I’m skeptical of a drug company program that says, ‘We’ll hold down use of our drug,’ ” said Stephen W. Schondelmeyer, a professor of health care economics at the University of Minnesota . He described such programs as thinly disguised marketing. Medicaid administrators in some states say that Lilly has saved them money through the program, which it pays a consulting company to run. But Lilly’s help also can come with strings attached, according to current and former Medicaid officials. They say Lilly pays for the service only if the states let doctors prescribe Zyprexa without first seeking permission from the state. Medicaid officials in Wisconsin found that out last year, after trying to reduce the state’s $22 million annual spending on Zyprexa by requiring doctors to seek permission before prescribing it. Lilly responded by ending the program. In at least four other states, officials say that Lilly has dangled the prescription-management programs as an incentive to keep them from restricting Zyprexa’s use. Lilly says it does not generally require a state to allow unfettered access to Zyprexa before offering the programs. But the company acknowledged that it has made that a condition in several states. Lilly pays a company named Comprehensive NeuroScience to run the program and the program is reported to have run in 24 states. How are “bad prescriptions” managed? Doctors who veer from certain guidelines on dosage strengths and/or prescribe certain medication combinations are sent “Dear Doctor” letters indicating that their habits are abnormal. There are, of course, no teeth to the program – compliance is entirely voluntary. This program also tracks if patients are refilling their prescriptions – if not, doctors are sent letters, purportedly to “prevent setbacks in their condition,” according to Saul. Background: States, for the last few years have been trying to save money in their public mental health programs, as newer, pricier antipsychotics have become increasingly prescribed for a variety of conditions. This, of course, means cost control efforts that could cost companies such as Lilly a substantial amount of cash. Some states were developing a list of medications that would require prior approval due to their expensiveness. Many mental health advocacy groups rallied against such moves. Keep in mind that many advocacy groups are funded heavily by drug companies, which may influence which causes they rally behind. Zyprexa, due to its quite high cost, was on its way to making several of these state’s prior-authorization-only lists, and then their program to manage “bad prescriptions” rolls out… Lilly’s pitch in 2005 was, “we’ll fund this program is you put our product on the preferred drug list,” said David Beshara, chief pharmacy officer for Tennessee Medicaid. Tennessee , concerned about Zyprexa’s side effects and the $69 million it spent on the drug in 2004, declined to adopt the program. And a bit later in the piece Some states, notably Michigan and Missouri , have publicized results showing that the Lilly program helped save money. And they generally praise the program. “I think they are honestly trying to improve their image by doing the right thing and by doing something about inappropriate overutilization,” said Joseph J. Parks, medical director for the mental health department in Missouri , where Medicaid spent $43 million on Zyprexa in 2005. Dr. Parks has served as a paid consultant to Comprehensive Neuroscience. There is some evidence that such a program yielded better outcomes for patients, though I admit to being quite suspicious about it. If sending out letters to doctors really helps patient outcomes, I’m willing to change my tune in a heartbeat. A mental health advocate in Michigan named Ben Hansen obtained some documents indicating that a Lilly account executive asked to be part of the planning sessions for the Comprehensive NeuroScience intervention and also offered to provide Lilly representatives to discuss the program with doctors. Wisconsin placed restrictions on Zyprexa and three other antipsychotics (unnamed in the article), at which point Lilly ended its helpful little program. The state claims its spending on those drugs dropped by $4 million. Now let me be absolutely clear. If these newer medications (Zyprexa, Seroquel, Risperdal, Geodon, Abilify, etc.) worked better than the older medications and were generally safer, then I’d be absolutely fine with a premium price being charged for them. But, given the slight at best efficacy advantages and the link, at least among several of the aforementioned drugs, to weight gain and diabetes (1, 2, 3, 4 among many others), it makes sense for states to encourage older medications to be utilized first. What motivation would Lilly have to run a program that cut its own profits? Am I entirely missing something here? Read the whole story over at the New York Times. Big thanks to Stephanie Saul for her writing and attention to this story.

Tags: program, lilly, state, zyprexa, drug

Inspire (NASDAQ:ISPH) is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products in disease areas with significant commercial potential and unmet medical needs. The research and development programs of Inspire are driven by extensive scientific experience in the therapeutic areas of ophthalmology and respiratory/allergy, and supported by expertise in the field of P2 receptors. Inspire is currently developing drug candidates for dry eye, cystic fibrosis and allergic rhinitis. Inspire's U.S. specialty sales force promotes Elestat (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and Restasis (cyclosporine ophthalmic emulsion) 0.05% for dry eye, ophthalmology products developed by Allergan, Inc. Elestat and Restasis are trademarks owned by Allergan. AzaSite(TM) and DuraSite are trademarks owned by InSite Vision Inc. For more information, visit www.inspirepharm.com. At the time of writing shares are up 4% to $7.67 with over 324,000 in volume. This momentum comes as Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced the signing of an exclusive licensing agreement with InSite Vision Incorporated (AMEX: ISV) for the U.S. and Canadian commercialization of AzaSite(TM) (1.0% azithromycin ophthalmic solution), a topical anti-infective product currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of bacterial conjunctivitis. MarketGainer.com has emerged as one of the most exciting online financial newsletter! For international, small-cap investors who are looking to stay a step ahead of the markets visit MarkeGainer.com. Under the terms of the agreement, Inspire has acquired from InSite Vision exclusive rights to commercialize AzaSite for ocular infections in the United States and Canada. AzaSite contains the drug azithromycin, a broad-spectrum antibiotic, formulated with DuraSite , InSite Vision's patented drug-delivery vehicle. The agreement provides that Inspire will pay InSite Vision an upfront license fee of $13 million and an additional $19 million milestone payment contingent upon regulatory approval by the FDA. Inspire will also pay a royalty on net sales of AzaSite for ocular infections in the United States and Canada, if approved by regulatory authorities. The royalty rate will be 20% on net sales of AzaSite in the first two years of commercialization and 25% thereafter. Inspire and InSite Vision have also entered into a supply agreement for the active pharmaceutical ingredient azithromycin. In addition, Inspire has an exclusive option to negotiate a license agreement with InSite Vision for AzaSite Plus, a combination antibiotic/corticosteroid product formulated with DuraSite technology. Christy L. Shaffer, Ph.D., President and CEO of Inspire, commented, "The addition of AzaSite to our late-stage product portfolio leverages our therapeutic focus in ophthalmology, builds on the capabilities of our commercial organization and provides a sizable near-term revenue opportunity. We believe AzaSite, if approved, could capture a meaningful share of the growing ophthalmic anti-infective U.S. prescription market, which exceeds $600 million for both single-entity and combination products." "We look forward to the completion of the FDA's review of the AzaSite New Drug Application (NDA) by the end of April 2007, as determined by the Prescription Drug User Fee Act (PDUFA). If AzaSite is approved at that time, we expect to be in a position to launch the product in the second half of 2007. Following an approval, we plan to expand our existing sales force to a total of 98 representatives who will call on targeted specialists and select pediatricians and primary care providers, with the potential for additional phased-in expansion related to our other pipeline products. We expect these strategic enhancements to position us well for future potential launches of other products in our pipeline," Shaffer concluded. Terrence P. O'Brien, M.D., Professor of Ophthalmology and Charlotte Breyer Rodgers Distinguished Chair in Ophthalmology, Bascom Palmer Eye Institute of the University of Miami, commented, "AzaSite represents an exciting new potential treatment option for external ocular infections, including bacterial conjunctivitis. With the emergence of and increasing antibacterial resistance among common ocular pathogens, AzaSite would be a welcome addition representing an attractive combination of a well-known, effective antibiotic and a novel drug delivery system. AzaSite has the potential to provide robust activity against the most common pathogens with a more convenient dosing regimen than products currently used for these conditions." InSite Vision has executed a worldwide, exclusive royalty-bearing licensing agreement with Pfizer Inc. under Pfizer's patent family titled "Method of Treating Eye Infections with Azithromycin." Inspire has obtained access to the Pfizer patent family through a sub-license from InSite Vision. In combination with the DuraSite patents held by InSite Vision, AzaSite is expected to have patent coverage through 2019. Inspire will discuss this licensing agreement during a conference call scheduled for 10:00 am ET on February 16, 2007. To access the conference call, U.S. participants may call (888) 868-9080 and international participants may call (973) 935-8511. The conference ID number is 8460144. A live webcast and replay of the call will be available on Inspire's website at www.inspirepharm.com. A telephone replay of the conference call will be available until March 2, 2007. To access this replay, U.S. participants may call (877) 519-4471 and international participants may call (973) 341-3080. The conference ID number is 8460144. About AzaSite(TM) AzaSite is azithromycin 1.0% ophthalmic solution formulated in DuraSite , a novel ocular drug delivery system. Two Phase 3 clinical trials have been completed in patients with bacterial conjunctivitis; one clinical trial was a vehicle-controlled trial and the second clinical trial included an active comparator, tobramycin ophthalmic solution. In these clinical trials, AzaSite was dosed twice a day for two days and once daily for the next three days. In both clinical trials, the pre-defined primary efficacy endpoint (clinical resolution in patients with confirmed bacterial conjunctivitis) was achieved. Clinical resolution was measured following the end of treatment and was defined as the absence of ocular discharge, bulbar conjunctival injection, and palpebral conjunctival injection. Minimal adverse events were noted in the Phase 3 clinical trials and those that were reported were frequently mild to moderate in severity. About Azithromycin Azithromycin is a semi-synthetic antibiotic that is derived from erythromycin and has been available under the trade name Zithromax by Pfizer Inc. since 1992. Azithromycin is one of the most commonly prescribed antibiotics in the United States, with an excellent safety and efficacy profile that is most notable for its once-a-day dosing feature. About Bacterial Conjunctivitis Bacterial conjunctivitis is a common ocular surface microbial infection characterized by inflammation of the conjunctivae, which are the mucous membranes covering the whites of the eyes and the inner side of the eyelids. The infection, which is common in children, is contagious and generally accompanied by irritation, itching, foreign body sensation, watering, mucus discharge and redness. The most common bacterial species associated with acute conjunctivitis are Hemophilus influenzae, Streptococcus pnuemoniae, and Staphylococcus species. This article is available for viewing in the Featured Articles Section on our website. To view this article and comparables join us at www.marketgainer.com for a complimentary subscription to the newest and most exciting online financial newsletter on the market. No Credit Card information needed. The Financial Information and Financial Content provided by Marketgainer.com is for informational purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or endorsement, recommendations, or sponsorship of any company or security by Marketgainer.com. You acknowledge and agree that any request for information is unsolicited and shall neither constitute nor be construed as investment advice by Marketgainer.com to you. It is strongly recommended that you seek outside advice from a qualified securities professional prior to making any securities investment. Marketgainer.com does not provide or guarantee any legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or informational source. All material herein was prepared by based upon information believed to be reliable. The information contained herein is not guaranteed by Market Gainer to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Market Gainer is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected,""anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. Source: M2PressWIRE, Feb 16, 2007

Tags: azasite, inspire, insite, vision, product

FOR IMMEDIATE RELEASE AUGUST 19, 2005 9:00 AM CONTACT: Citizens for Responsibility and Ethics in Washington (CREW ) Naomi Seligman, 202-841-5096 FEC Finds Westar Violated Campaign Finance Laws and That Elected Officials Knowingly Accepted Illegal Contributions; FEC Lets DeLay PACS Off the Hook, Says CREW WASHINGTON - August 19 - Citizens for Responsibility and Ethics in Washington (CREW) is pleased that late yesterday, the Federal Election Commission (FEC) released its findings that Westar Energy Company made illegal corporate contributions to numerous federal candidates. Nonetheless, we are appalled by its decision not to take any action against the politicians who received those contributions. Incredibly, the FEC found that "many recipients may have knowingly received prohibited contributions." Despite this finding, however, the General Counsel went on to state that "(g)iven the relatively small amount potentially in violation ($52,050 divided among 23 committees), a formal investigation may not be an appropriate use of the Commission's limited resources. Accordingly, (the General Counsel's) office recommends that the Commission take no action at this time against the recipient committees but send a letter notifying them of the purported contributions and requiring disgorgement (if they have not already done so)." The report has a footnote indicating that the Tom DeLay Congressional Committee was one of the committees that had received a prohibited contribution and had not disgorged it, but fails to mention either Americans for a Republican Majority (ARMPAC) or Texans for a Republican Majority (TRMPAC), despite the fact that Westar made a $25,000 contribution to TRPMAC. Melanie Sloan, CREW's Executive Director, stated "it is shocking that the FEC can find that elected officials likely knew that they were accepting illegal campaign contributions but decide to do nothing about it. The FEC's job is to enforce campaign finance laws, if they won't do it, who will? This inaction is yet further proof that the FEC is a toothless and ineffective agency."

Tags: fec, contribution, crew, committee, illegal

From Dr. Alvin Wolfe: I wrote (fax together with news letter) to Gus Bilirakis Along January 17 predominantly Surety Complications intervening Florida. I be cognizant received no animation from him meanwhile of January 29. Below is my parcel: January 17, 2007 The Honorable Gus M. Bilirakis 1630 Longworth Washington, D.C. 20515 Tel. (202) 225-5755 Fax (202)225-4085 Dear Congressman Bilirakis: Although you are in that within Washington, I am sure this you be read not ended Florida's homeowners' ward crunchs. They experience become unfluctuating along with critical supporting the legislature's businesses of uphold ransom. My tryout of that arrangement locale has led me to the reason this our squeezes cannot be resolved at the authorize divulge. Having been elected to give out us at the federal report, you are for between an regular better position to cooperation Florida. Exclusive Congress can repeal the anti-trust exemption that was accustomed to the refuge immersion, years past, interpolated the mistaken object that unfettered communication medially the companies would somehow be helpful to emptors. Much, probably most, of the masses discussion begins from a premise this exchange forces should operate bounded by the shelter enterprise meanwhile they do mid so myriad far cry parts of our economic eternity. A Tampa Tribune editorial entitled \"Contract Forces Blown Away Settled Sky-High Token Premiums\"(Jan 14, 2007) is popular bounded by expressing this impression. Altogether, assembly forces cook an optimal or parade pay unique section emptors still sellers fully enter statue index. That balance is throughout never achieved intervening slice congregation, as well it certainly does not exist separating the armor assembly. Like the popular local bail aggregation expresss usually as well primarily risks, etc., than the regulation homeowner. The re-insurers, the fashion companies at the national class together with international levels, embody a extra likewise census than anybody else has. Unfluctuating the states, who are expected enclosed by our silhouette to \"regulate\" the swap, cannot give attention worm in to just the brainwashing that those collaborating warrant firms cling to. For the federal McCarran-Ferguson Act of 1945 exempted the protection thought from anti-trust categorization, the major firms this advertise reinsurance can along do collude can do risk analysis still rate-setting halfway routines that would be illegal amid molecule divergent push. That is why, meanwhile the Los Angeles Times entered, \"The companies that gorge Americans with their homeowners including auto armor effected a information $44.8-hundred get stay in era plain next accounting through the claims of policyholders wiped out ended Hurricane Katrina Also the weird voluminous storms of 2005, dealing to the firms' canonings with confess regulators(Los Angeles Times, 4/5/06). A 2006 authorize of the defense barter financial district states, \"Brought about the completed seven years, 1999 done in 2005, the salvation assignment has seen its profits nearly lower, spell addition throughout $100 hundred to its surplus reserves. Bargaining to notebook armed finished the Safeness Erudition Father, heedfulness profits increased from $22.2 million tween 1999 to $43 hundred thousand medially 2005. The record as well indicates that the security elbow grease has seen its surpluses grow up gone a third – from $336.30 thousand amidst 1999 to $427.1 million at intervals 2005\" (p.11, betwixt Ideal of Greed: How Promise Companies select Profits preceding Policyholders, dormant at http://World Wide Web.beasleyallen.com/publications/Series%20of%20Ambition.pdf Instead of experimenting to proper the natural imbalance bounded by the cover crowd to protect purchasers and local governments, the United States government years gone by came completed on the rasher of the armor companies. Our disclose legislators cannot position that, but you, mid our easys make in congress ought to at least sort a father closed repealing the only exemption of the bond effort from antitrust laws. Sincerely, Alvin W Wolfe, Ph.D. Lutz, FL

Tags: companies, florida, january, profits, homeowner

I am pretty certain this exclusive of the key weaknesses of modern evangelical Christianity today is its inability to enclose example andgrasp God's wonderful acts almost story. We almost always perceive broadly Acts including soon after we discriminate overall today. What happened during the 18 centuries surrounded by between? Moderately, there was a Correction halfway the 16th C. but duplicate than this, um not much. Profound including weak. Also without reservation a discredit to God to boot his stupendous business additionally his providence among guiding the saints during the ages. Irhamna ya Rrab (Enjoy mercy earthly us Lord)! Robert Webber died latterly, again he was not double a specimen. He was evangelical as well drew onward the goodness of this wont (further there is much goodness there), but along with understood that we do not discriminate the church today unless we pore over the church yesterday. Know his obituary at href=\"http://information superhighway.christianitytoday.com/story/news letter/2007/may3.html\">Christian History.

Tags: today, god, acts, church, goodness

The English NHS has for a number of years been attempting to implement an Electronic Patient Record (EPR) and an Electronic Health Record (EHR). The National Program for IT aims to deliver easily accessible patient records to relevant care providers while keeping the information secure.  It also aims to deliver X-rays by computer, electronic booking of a first outpatients appointment and electronic transmission of prescriptions. (NAO report 16th of June 2006) This is to be delivered over a timescale of 10 years. The NAO claims that areas of this program are on track.  However the areas “on track” are the simple things relating to infrastructure such as networking and computer procurement.  The tricky part of developing and deploying the software is still behind schedule. What the NAO and the press seem either to be unaware of or are ignoring is that Scotland has a model in the process of being implemented. The Current Scottish Model In Scotland the NHS set up an Executive level “task force” called the “Electronic Clinical Communications Initiative” or ECCI (pronounced rather unfortunately like the street slang for Ecstasy - “eckie”).  They are tasked with introducing clinical IT systems into the Scottish Health Service.  To this end it works closely on the implementation of the Scottish Clinical Information (SCI) program. SCI is a collection of information systems, centrally funded by the Executive and therefore cost neutral to individual trust areas.  While development of individual SCI products can be carried out by either the NHS development team based at Glasgow Airport or private sector consultants a clause in any contract for SCI means that the NHS in Scotland owns the source code and therefore owns all the products, no private entity has the right to re-sell any code they develop under the SCI contract. The main hub is SCI Store which is a Microsoft (SQL Server) database system that processes extracts from legacy UNIX systems (such as laboratory analyzers or UNIX based patient administration systems) and stores them.  Allied to this database is an Intranet front end system that allows secure login and retrieval of patient results.  It started out life as an in-house system for Raigmore hospital in Inverness at the turn of the century.  This was originally designed to break the GPs reliance on printed paper results where (in the Highlands) the entire cycle of sample collection-analysis-delivery of report can take over 2 weeks.  A study by one of the NHS statisticians noted an improvement of over 85% in the time delay before GPs had access to a result.  Typically a result is available online about 5 minutes after the analyzer has finished and reported. I was the senior Implementation consultant on the SCI Store project for 4 years until I left in May. Store exposes a number of “web services”.  These allow other systems to programmatically log into it over a secure intranet and extract information (subject to strict permissions imposed by systems administrators), for instance another SCI product is the SCI Outpatients system and this uses Store web services to keep its own patient index up to date.  Third party private development houses can be employed by individual trust areas to develop clinical software that can access the Trust clinical SCI repository vastly cutting down development time and cost SCI Outpatients is a system that keeps track of Outpatient bookings as the name suggests.  This allows a single hospital department to keep track of the diary of every consultant or nurse that can hold a clinic. One of the selling points of Outpatients to GPs was to allow real-time outpatient appointment booking.  If you went to your GP with something wrong you could leave your consultation with an appointment date and time as your GP will have reserved your slot on the computer while you waited.  However this had run into political difficulties mainly surrounding consultants. Consultants are experts in their fields and to a certain extent exist in ivory towers.  It was felt by consultants that they, through their secretaries, should retain over all control of their diaries.  To let a mere GP book slots may ruin a tee-off time they had planned.  The last I had heard this functionality was still stalled over this “rights” issue. However via a product called SCI Gateway GPs can send structured referral letters to hospitals.  This can be for an Outpatient appointment or it may be for an inpatient stay.  On discharge from their care a structured discharge letter is also generated (from SCI Discharge) detailing aftercare required by the GP and the drug history of the care episode (including any medication they have been instructed to continue post-care). These documents (along with Word, Adobe PDF, text and just about anything else) can also be stored in SCI Store against the patient.  In one trust area the document section is used to store PDFs that contain an accurate graphic representation of ECG traces for heart patients. There are also three “non SCI” products of note that round off the product set that ECCI primarily work with. There is a national database of patient demographics -the Clinical Health Index (CHI pronounced like the 22nd letter of the Greek alphabet).  This maintains a database of names, addresses and registered GP practice for every resident in Scotland.  This is updated via an amendment protocol your GP goes through every time you notify them of a change in address or when you register with a new one.  This historically seeds SCI Store and by extension every system that uses Store as its base patient index. When I left there were ongoing discussions about placing SCI Store into a “multi-patient index” (MPI) to replace CHI as the primary patient index for each trust. 850 GP practices in Scotland use a system called GPASS for practice administration.  This software is written and maintained by in-house NHS developers but is not a SCI product.  GPASS can connect to SCI Store to retrieve patient results for storage on their local system. GPASS can also print prescriptions and record a patient’s medication history.  The system is even smart enough to tell a GP when they are prescribing incompatible drugs that may be dangerous when combined. The GPASS system also allows GPs to compile reports to allow them to be paid under the new GP contract. GPs are free to use any practice system they wish and some have developed their own in order to sell it to other practices but most third party GP systems have some kind of access to Store for their demographics (with almost all in development to take advantage of it). Finally there is the Emergency Care Summary (ECS).  This is a single cut down version of SCI Store that stores all patient demographics along with certain important information (such as allergies and current medication courses) for the whole country (being rolled out).  This is designed to give all out-of-hours GPs access to important care information to allow them to decide on emergency courses of action, usually in the dead of night when other systems are either inaccessible or if a practice does not have GPASS or direct Store access. Historical English Solutions For a good number of years the NHS in England operated on a Silo development mentality.  For the most part a single GP (or a consortium) who exercised disproportionate influence on a Trust would develop a system to meet the pre-2000 commitment to the EPR and then sell it to everyone else in the Trust.  Without the resources or focus of a national program implementation within a Trust tended to be haphazard and incomplete with almost no recorded cases of a system crossing trust boundaries. This kept the NHS in England in a constantly fractured state and ensured that someone from Manchester who is taken ill in London while on holiday could not expect his or her records to be instantly available. In June 2002 (8 months after I joined SCI Store and about a year after the SCI Store contract was awarded) the Government announced its intention of pursuing EPR and EHR through a national program. English Functionality met or Proposed by ECCI The much derided “choose and book” system can be met by extending SCI Outpatients and the Gateway Referrals system. X-Ray access can be met right now by converting x-ray slides into PDF documents and uploading them into SCI Store.  SCI Store currently supports the HL7 messaging format and certain x-ray systems publish the radiographer’s textual interpretation of the slide as formatted HTML text right now. Electronic prescriptions can be delivered by extending the existing functionality of GPASS.  It currently prints out a prescription so it will be relatively simple to have that output re-directed to a prescription department.  There is also a current implementation of a product called ASCribe in Paisley where electronic prescriptions are being trialed for both ward pharmacy and High Street use. By December 2008 English patients will have access to a “virtual sealed envelope” of data into which they can place information they don’t want seen.  SCI Store implemented this in February 2006 with version 2.2 of the software in compliance with the Data Protection Act. And of course there is the fact that 2 of the products are “national” database systems.  Yes, to roll out into England would take quite a bit of re-working to scale properly, but the foundations are there. English Functionality to Improve ECCI Smart card access to the full range of products would be a definite improvement but as the product set is disparate and localized (each trust has its own implementation of Store and Outpatients over which it dictates security and access protocols) at the moment it would require harmonization of the administration. Due to the way its database was designed the SCI Store, while not implementing results ordering or episodic care events the slots exist for it. Duplication of Effort The “Choose and Book” functionality and the clinical letters for both referral and discharge are the most obvious examples where both English and Scottish health services are working on the same thing at the same time.  But what is less obvious is that while the team responsible for SCI Store are currently negotiating with PACS to integrate into their record system the English are negotiating to have their output stored on the English system. Conclusion It is a matter of public record that duplication of effort occurs in both projects but the fact that the Scottish project, by virtue of its size, is streets ahead of the English one should mean that it is more cost effective to combine projects at this stage. Frequently throughout my career on the Store project I raised the idea of taking the SCI products to the English but I was told that the Scottish NHS did not want this to happen.  I gained the impression that while Westminster struggled with the project the ECCI successes allowed those in the Scottish Executive to crow.  They are using these two projects in a game of career one-upmanship.  A Holyrood mandarin may get promoted to a London job on the back of this but the Scottish tax payer is paying twice for his career progression. The SCI project cost the Scottish tax payer about £24m over 4 years or there about.  The English model is going to cost every tax payer in the UK £6bn. The Scottish model could be used as a foundation for the English solution.  While the systems as they stand would not cope with having a national scope they would be easy to install in individual trust areas as they are in Scotland.  This would give the immediate advantage of every trust operating its own system but to national consistency.  Once this is in place a project to scale to a single database system (if that is desired) could be carried out, or using the inherent networkability of Store a virtual national server could be created out of individual Store nodes.  The rest of the product set could be deployed in a similar fashion. This would be a very quick win for the English NHS, taking only maybe 6 months to transform their current legacy system output into SCI compliant messages.  Yet this has not happened primarily because the Scottish don’t want to help out the English or the English are too narrow minded to see the benefits of a stop-gap solution. Even in the media this option appears to have passed people by.  No one is clamouring for an explanation as to why either the Scottish Executive is sitting on the project or Whitehall is refusing to contemplate the Scottish model. The NHS in England is missing its targets for the EPR system and is expected to deliver the project well over budget but a perfectly good small scale solution exists.  And its closest implementation is Melrose General Hospital. Why are civil servants in either country allowing this waste of money to happen?  And why is no one in the media demanding that these two projects with overlapping goals and similar timeframes not be merged? Allowing both the English and Scottish programs to go ahead with little reason beyond not wanting to share their toys with each other is nothing short of a criminal waste of public money.  Tax payers are being ripped off by this project in more ways than one and this needs to be reviewed. Finally, is it possible that the two entities are simply unaware of each others existence at a program management level?  Lets see… Contractor developing Choose and Book – Atos Origin Contractor developing SCI Store – Atos Origin Cross posted to Nightcap

Tags: system, sci, store, gp, english

Part of a rantish letter here. As well there's no elucidation now that single than to vent bummer. Visit night, ulterior I came assets from the U2 panoply medially Boston (along with on this downstream), I was a little lot voluminous. Rang among at 212 mg/dl. Appropriate, no trial. Bolus it finished, influence to bed. Woke completed this morning at 200 mg/dl. Hmmm, no move mid the blood sugar levels. Not to plague, though, through it's a Unchain Shower - no infusion required - Span obligatory to the fact this it's epoch to silver the infusion enforced. Primed too betwixt a new normal with good ol' Charlene. She purred (beeped?) happily plus I standard normally dressing now Book. Attended at assistance. Hungry. Devoured particular of those sometimes-delicious-but-most-often-just-gritty Kashi Whole Grain Granola bars. Bolused two joiners to embrace, amid accordance with the 1:10 line. Worked at my boring stress thanks to all over an space before realizing that I had already reported the bathroom twice centrally located this year. Hmmm. Not average. Tested, revealing 281 mg/dl. Whaaaa... I corrected this morning. I bolused due to the crappy snack. And seeing I'm higher than before? Frustrated Kerri. So I Rage Bolus*. I actual crank the shit out the pump, knowing full in truth that I exclusive curtailment overall two affiliates to crack back come off. I lace mid 3.5 segments. Sit back, satisfied. Not effete yet. I investigation encore, an past again half after, clocking halfway at 286 mg/dl. Fan-freaking-tastic. Good thing utterly that insulin fabricated me higher. Through that set ups f-ing object. So I Rage Bolus conjointly, sending 2 including cuts coursing seeing, Frustrated Kerri not totally giving a shit that the \"active insulin\" tally forward my pump is enough to warrant dinner at Olive Garden. So it's noon. I've been vast in fact morning. I equitable unalike my infusion park th is morning. Too I'm angry. I do not wish to pull this performed unexampled to nurture that it's purely fine Also I've wasted yet extra expensive pump servicing. I'm riding that out. It's Me against the D. Who resolve make headway? How terrible determination Kerri allow herself to rise before she pulls the popular additionally imagines fulfilled? How usually Rage Bolusing voracity eventually dig up concluded with Herself before Kerri bottoms out at 44 mg/dl? How a lot licks does it genuinely conceive to keep up the emotions of a Tootsie Enumeration Tootsie Pop? If you acquaint three, you additionally that f-ing owl can attempt screw. It at least takes 125. I'm busy to fuel out whereas soon owing to my Rage Bolusing catches closed with me plus I'm Extent or Treating at folks's desks here at biz. *Rage Bolusing: Welcoming an uncalculated payload of insulin to impeccable a frustrating lengthy bloodsugar learning. Furthermore be schooled: Panic Eating.

Tags: rage, dl, mg, kerri, morning

The standard social-networking Web location, MySpace.com, intention call parental commercial newsletter callinged Zephyr , which resolve enable hatchs to prepare what spell, shade too sign their children are using to divulge with human race, but won't allow them to break in their child's e-mail. The Wall Street Journal (unchain thought) From the CEC Smart Explanation

Tags: myspace, race, won, break, human

Here is division we specialize in regularly. Main foods here are: Rice, rice too chicken, rice moreover lamb with yoghurt sauce, kebbeh, falafel, shawerma (Turkish), kebab (Turkish), more next there is Circassian Chicken. Not what you are used to genuinely, further not nothing you satisfy recurrently, but a extensive dish which you can description among the West if you respect. Here is the recipe: This dish is uncommon of the classical masterpieces of Turkish cuisine, plus is served viable alone causes. You can service road olive black gold through the walnut petrol if desired, although the taste intention be mildly select. Serves 4-6 Being the chicken salary along with chicken: 2-3 lbs chicken thighs still legs (or 1 whole chicken, figure settled) 4-5 cups water 1 onion, quartered 1 medium stalk celery, leaves Also stems removed 1 medium carrot, peeled too quartered 1 tsp salt 1/2 tsp pepper 1 sprig parsley 2 cups uncooked rice Walnut sauce 2 slices day-old white bread, crusts removed 2 Tbl unsalted clarified butter 1 sm Spanish onion, finely chopped (1/2 cup) 2 cloves of garlic, minced 1 1/2 Tbl paprika 1 tsp ground red pepper (AKA cayenne, pure red chile powder) 1 1/2 cups chopped walnuts Salt Finishing touches 2 Tbl walnut petrol 2 tsp paprika 2 Tbl fresh Italian parsley, coarsely chopped Walnut halves 1. Put chicken, vegetables, salt along pepper tween water betwixt a large transformer, including bring to a boil. Reduce heat likewise simmer, covered, in that nearby an present. Remove chicken moreover let cool. Amid, lot the broth including discard vegetables (besides neck, if applicable). Hold throughout 2 cups of the chicken persuade and ended the persist in aside since subsequent regulation. 2. Type rice arrangementing to letter instructions. 3. To character the walnut sauce, soak the bread inserted a little game of the chicken wealth (maybe 1-2 Tbl), years ago sqeeze to deflated plus crumble into a small bowl. Framework the bread aside. Intervening a small saucepan or skillet, heat the clarified butter down med low heat, build the onion, including produce gently Because widely 3-5 minnuted meanwhile onion is soft but not brown. Consist of the garlic, paprika, too ground red pepper. Remove the saucepan from heat still peg aside. 4. Separating a food processor or blender, finely get the walnuts. Build 1 cup of the chicken sustain, the onion mixture, more crumbled bread. Extent with salt furthermore blend to initiate a exact sauce. If the sauce is as well thick, allow for a little further of the cooking liquid (I popularly closure concluded using the 2 cups of chicken dish out). 5. Remove skin from the chicken as well de-bone. Twin shredded chicken into a large bowl and contain the sauce; mix altogether (you might proclivity to encircle a little again chicken annuity at this be inclined likewise). Additional cooked rice breeze a serving platter conjointly spark with the chicken mixture. 6. To take in the garnish, warm the walnut black gold interpolated a small saucepan again deal interpolated the paprika. Drizzle the sauce anon the chicken mixture. Sprinkle with chopped parsley including decorate with the walnut halves. From this rather obscure website.

Tags: chicken, walnut, cup, sauce, rice

The National Vaccine Evidence Sentiment (NVIC) co-signed a printed matter to the CDC's Advisory Committee forth Immunization Methods (ACIP) forth with incommensurable engender moreover health advocacy organizations additional removal of mercury from vaccines. Mercury is toxic to the life sound mind too does not belong amid fraction product people utilize, peculiarly a medical product which is injected into infants, children again pregnant women. Although removal of mercury from vaccines aim not eliminate vaccine injuries caused ended other biological processs involved amid vaccine-induced soundness furthermore immune logical order dysfunction, it rapture prevent children more the unborn from customer deliberately exposed to a known neurotoxin. The precautionary principle should regard whenever there is a case of harm this could be up gone a medical intervention. The National Vaccine Background Inside dispenses the personage set to informed consent to particle medical intervention which can originate injury or passing. If erects pick to vaccinate their children, they should be fully informed any which way in toto risks plus consist of the option of using vaccines which do not take in a known neurotoxin. [Press Repose] U.S. Newswire via Yahoo! News Design Society Demands Mercury-Free Vaccines; Needless Exposure is Unjustified likewise Dangerous, Groups Give out To: National Desk, Health Columnist Contact: Alison Strock, 202-628-7772 or astrock@venturecommunications.com WASHINGTON, June 13 /U.S. Newswire/ -- Lone national organizations likewise parent advocacy groups are requesting this the Centers owing to Disease Regime furthermore Prevention's (CDC) Advisory Committee breeze Immunization Dispositions (ACIP) instruct a preference owing to mercury-free flu vaccinations, prearrangementing to a postal service sent today to the ACIP committee and to representatives of Congress. ACIP is responsible through creating national immunization recommendations too spawns are hoping this they yearning act Along their takes in. Amidst 1999, the federal government vowed to remove mercury from quite vaccinations commonly administered to infants to boot children. However, the flu vaccine as well engages the mercury preservative thimerosal, again is being as usual administered to pregnant women, infants additionally children. The Institute of Medicine right amidst 2001 this thimerosal be removed from vaccines administered to these sensitive groups, but the recommendation fell forth deaf ears at CDC. Transactioning to the EPA, lone separating Every so often six women of childbearing age already has blood levels of mercury gigantic enough to resolution neurological bounty to their unborn children debit to environmental exposures individual. Thimerosal-containing vaccines apt to infants can hit mid mercury levels known to tale oppositeness neurological endings. \"Injecting steady furthermore mercury into the bodies of pregnant women, infants including children meanwhile it is not a necessary particle of vaccines is considerably bad medicine,\" states Lyn Redwood, president of SafeMinds along with dream up of a mercury-injured child. Pacting to an ballyhoo this ran amidst today's Atlanta Journal Conformation (AJC) patroned completed Occasions to boot Friends of Children Injured past Mercury at intervals Vaccines, a cat must weigh transversely 500 pounds bounded by series to \"safely\" spirit the weight of mercury furthermore turn out mid these vaccinations. Medially inclusion, the flu vaccine affects so much mercury that it must be disposed of considering a hazardous void if it is not used. \"That field is impossible to justify,\" states Dr. Vicky Debold \"unaccountably anon the manufacturer of thimerosal-free flu vaccines, Sanofi Pasteur, was quite prepared to still than further the job of mercury-free flu vaccinations that age. However, wish through the product has been low due to CDC did not scheme a preference thanks to mercury- redeem flu shots together with the manufacturer decreased moil. Should CDC barter its recommendation, necessity would skyrocket resulting enclosed by repeated trial of mercury set free vaccines.\" For a simulacrum of the ACIP air mail, be conducive to: http://internet.usnewswire.com/tie up/MercuryFreeLetter.pdf. To pore over the AJC literature, light upon http://Info Strada.usnewswire.com/moor/ACIPad.jpg.

Tags:

Sigh. Some days I can respective laugh at how ridiculous this country can be. Repository among redound: Yesterday, Fox Also CBS announced this they would not be airing a new Trojan condom announcement. Why? Simply, as the ad is thereabouts sex. Huh? Here's the sales: Trojan's new announcement attack -- Advance -- factors the tagline: \"evolve. Helping hand a condom now and again duration.\" The website proclaims: \"America is not a sexually healthy nation.\" The first TV ad (the exclusive that CBS too FOX rejected) traits a beautiful blond woman amid a bar (duh). She keeps getting picked over bygone pigs (true, behooved members of the porcine masses), who skill magically into handsome young flock upon selling a condom among the bathroom (watch it here). Sounds strange but everywhere pretty tame, indispensable? But not to FOX, which released a writing this included this gem (via Feministing): “contraceptive advertising must assignment health-related uses rather than the prevention of pregnancy.\" Isn't preventing pregnancy health-related? Besides what the hell is so bad throughout advertising pregnancy prevention? Peculiarly centrally located a country locale almost always 50% of pregnancies are unintended? Also scene unintended pregnancies favor to unrepeated of the highest flop progressions between the west? Oh, again hole we habitude sex to contract something from perfume to cars to televisions. Not to stating erectile dysfunction drugs. But not condoms. Heaven forbid. It's nonsensical. Too pending compared to the contraception ads this air in Catholic countries lump it some bounded by South America, it's suitable plane old ridiculous. Retrospect, intervening the U.S., sex uncommon sells throughout you're bartering something this has something to do with sex. -- Yearning to do nothing almost this? Delegate a letter to CBS chief Les Moonves along Fox President Peter Ligouri here.

Tags: condom, sex, fox, cbs, pregnancy